SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The GUMMMy Bear Squad touting Gum Tech (NASDAQ: GUMM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Carl R. who wrote (116)2/2/2000 8:36:00 AM
From: Mike M  Read Replies (2) of 207
 
Carl,

That is a good and reasonable response. It represents the gist of my expectation. I would only add that GUMM has been geared up for international sales but was unable to satisfy US market until now. Given that goal then, I think they may well sell all the Zicam they can manufacture this quarter.

Furthermore, although colds are certainly more prevalent in the winter they occur year around. This product will have a place on the shelf in the summer as well. This may be particularly so because many people have indicated an anecdotal relief from allergy symptoms attributed to Zicam. The product shelf life is long etc...

I agree that mad2's logic is clear and not unreasonable. He may be right but I am sticking with my expectations until proven wrong.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext